Company
BeyondSpring
BeyondSpring has 6 drugs tracked on RxWires: 3 in Phase 3, 1 in Phase 2, 1 in Phase 1/2, 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Docetaxel + Plinabulin (DP) | Phase 3 | Non-Small Cell Lung Cancer |
| Pegfilgrastim | Phase 3 | Chemotherapy-induced Neutropenia |
| Plinabulin | Phase 3 | Chemotherapy-induced Neutropenia |
| Pembrolizumab in Combination with Plinabulin and Docetaxel | Phase 2 | Non Small Cell Lung Cancer Metastatic |
| Nivolumab | Phase 1/2 | Lung Cancer |
| Nivolumab + Plinabulin | Phase 1 | Non-small Cell Lung Cancer Metastatic |
Latest
- beyondspring filed 8-K
- beyondspring filed 8-K
- beyondspring filed 8-K
- beyondspring filed 8-K
- beyondspring filed 8-K
Follow BeyondSpring on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.